The Impact of COVID-19 on Psychiatric Health in the Korean Population.

COVID-19 Health Korea Psychiatry SARS-CoV-2

Journal

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology
ISSN: 1738-1088
Titre abrégé: Clin Psychopharmacol Neurosci
Pays: Korea (South)
ID NLM: 101207332

Informations de publication

Date de publication:
31 Aug 2023
Historique:
received: 08 04 2023
revised: 21 05 2023
accepted: 22 05 2023
medline: 10 7 2023
pubmed: 10 7 2023
entrez: 10 7 2023
Statut: ppublish

Résumé

Coronavirus disease 2019 (COVID-19) has multiple negative impacts on the psychiatric health of both those previously infected and not infected with severe acute respiratory syndrome coronavirus 2. Moreover, the negative impacts of COVID-19 are closely associated with geographical region, culture, medical system, and ethnic background. We summarized the evidence of the impact of COVID-19 on the psychiatric health of the Korean population. This narrative review included thirteen research articles, which investigated the impact of COVID-19 on the psychiatric health of Koreans. COVID-19 survivors were reported to have a 2.4 times greater risk of developing psychiatric disorders compared to members of a control group, and anxiety and stress-related disorders were the most common newly diagnosed psychiatric illnesses. Studies also reported that COVID-19 survivors had a 3.33-fold higher prevalence of insomnia, a 2.72-fold higher prevalence of mild cognitive impairment, and a 3.09-fold higher prevalence of dementia compared to the control group. In addition, more than four studies have highlighted that the medical staff members, including nurses and medical students, exhibit a greater negative psychiatric impact of COVID-19. However, none of the articles investigated the biological pathophysiology or mechanism linking COVID-19 and the risk of diverse psychiatric disorders. Moreover, none of the studies were actual prospective studies. Thus, longitudinal studies are needed to more clearly elucidate the effect of COVID-19 on the psychiatric health of the Korean population. Lastly, studies focusing on preventing and treating COVID-19-associated psychiatric problems are needed to provide a benefit in real clinical settings.

Identifiants

pubmed: 37424410
pii: cpn.23.1083
doi: 10.9758/cpn.23.1083
pmc: PMC10335912
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

410-418

Références

N Engl J Med. 2009 May 21;360(21):2153-5, 2157
pubmed: 19423867
J Pers Med. 2021 Oct 09;11(10):
pubmed: 34683156
BJPsych Open. 2021 Oct 01;7(6):e183
pubmed: 34659793
PLoS One. 2022 Sep 12;17(9):e0273637
pubmed: 36094911
BMC Public Health. 2010 Mar 30;10:172
pubmed: 20353554
Clin Psychopharmacol Neurosci. 2021 May 31;19(2):294-302
pubmed: 33888658
PLoS One. 2022 Oct 31;17(10):e0277059
pubmed: 36315569
Sleep Med Rev. 2022 Apr;62:101591
pubmed: 35131664
SN Compr Clin Med. 2020;2(11):2037-2047
pubmed: 33083695
Front Psychiatry. 2021 Jun 22;12:642918
pubmed: 34239459
Front Psychiatry. 2021 Jul 07;12:611108
pubmed: 34305663
J Clin Sleep Med. 2021 Feb 1;17(2):299-313
pubmed: 33108269
Front Psychiatry. 2022 Jul 22;13:934202
pubmed: 35935440
J Health Soc Behav. 1983 Dec;24(4):385-96
pubmed: 6668417
Psychiatry Res. 2022 Jul;313:114615
pubmed: 35567852
Lancet Psychiatry. 2020 Apr;7(4):e20
pubmed: 32085842
Clin Psychopharmacol Neurosci. 2022 Feb 28;20(1):97-108
pubmed: 35078952
Int J Environ Res Public Health. 2021 Jul 10;18(14):
pubmed: 34299829
Cancer Res Treat. 2022 Jul;54(3):671-679
pubmed: 34583461
Int J Psychiatry Med. 2022 Jul;57(4):323-337
pubmed: 34425688
Clin Psychopharmacol Neurosci. 2022 Feb 28;20(1):185-189
pubmed: 35078961
BJPsych Open. 2022 Sep 08;8(5):e166
pubmed: 36073010
JMIR Infodemiology. 2021 Nov 12;1(1):e32127
pubmed: 34841200
Am J Alzheimers Dis Other Demen. 2022 Jan-Dec;37:15333175211072387
pubmed: 35050807
Respirology. 2010 Apr;15(3):543-50
pubmed: 20337995
Clin Psychopharmacol Neurosci. 2022 May 31;20(2):199-210
pubmed: 35466092
Compr Psychiatry. 2009 Jul-Aug;50(4):385-90
pubmed: 19486738
PLoS One. 2022 Jul 12;17(7):e0271059
pubmed: 35819941
Neurochem Res. 2023 Apr;48(4):1015-1025
pubmed: 35922744
Psychiatry Investig. 2022 Aug;19(8):676-686
pubmed: 36059057
Crit Care Med. 2021 Sep 1;49(9):1427-1438
pubmed: 33769771
J Neuroinflammation. 2022 Sep 7;19(1):222
pubmed: 36071466
Lancet Psychiatry. 2021 Feb;8(2):87
pubmed: 33485416
BMC Public Health. 2006 Sep 14;6:230
pubmed: 16970828
Psychiatry Investig. 2021 Nov;18(11):1082-1090
pubmed: 34710959
Clin Psychopharmacol Neurosci. 2023 Feb 28;21(1):2-9
pubmed: 36700307
Cancer Cell. 2020 Aug 10;38(2):161-163
pubmed: 32710820
Scand J Work Environ Health. 2020 Nov 1;46(6):639-644
pubmed: 32905601
Int J Soc Psychiatry. 2020 Jun;66(4):317-320
pubmed: 32233719
Neuropharmacology. 2022 May 15;209:109023
pubmed: 35257690

Auteurs

Sheng-Min Wang (SM)

Department of Psychiatry, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Department of Psychiatry, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Sung-Hwan Kim (SH)

Department of Psychiatry, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Department of Psychiatry, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Won-Seok Choi (WS)

Department of Psychiatry, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Department of Psychiatry, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Hyun Kook Lim (HK)

Department of Psychiatry, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Department of Psychiatry, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Young Sup Woo (YS)

Department of Psychiatry, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Department of Psychiatry, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Chi-Un Pae (CU)

Department of Psychiatry, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Department of Psychiatry, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Korea.

Won-Myong Bahk (WM)

Department of Psychiatry, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Department of Psychiatry, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Classifications MeSH